Contact Information

37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG

We Are Available 24/ 7. Call Now.
FDA Approval Isn't Always a Happy Day for Biotech Investors
Business

FDA's OK Isn't Always a Happy Day for Biotech Investors

In recent weeks, three closely watched FDA decisions came in positive for the companies—followed by their stocks going negative. Source link

FDA Approval Isn't Always a Happy Day for Biotech Investors
Finances

FDA Approval Isn't Always a Happy Day for Biotech Investors

In recent weeks, three closely watched FDA decisions came in positive for the companies—followed by their stocks going negative. Source link

Biotech firms target weight-loss drugs without Wegovy's side-effects By Reuters
Stock Market

Biotech firms target weight-loss drugs without Wegovy’s side-effects By Reuters

© Reuters. FILE PHOTO: A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S.,

Freeport-McMoRan (FCX) Declares $0.08 Dividend
Business

HC Wainwright & Co. Initiates Coverage of Legend Biotech (LEGN) with Buy Recommendation

On March 29, 2023, HC Wainwright & Co. initiated coverage of Legend Biotech with a Buy recommendation. Analyst Price Forecast Suggests 51.50% Upside As of

Freeport-McMoRan (FCX) Declares $0.08 Dividend
Business

RBC Capital Initiates Coverage of Legend Biotech (LEGN) with Outperform Recommendation

On March 24, 2023, RBC Capital initiated coverage of Legend Biotech with a Outperform recommendation. Analyst Price Forecast Suggests 57.86% Upside As of March 25,